Voss Value Master Fund, LP, 10% Owner at Rein Therapeutics, Inc. (RNTX), bought 208,366 shares at $1.22 ($254K) on 2025-11-14, disclosed to the SEC on 2025-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 104,183 | $127K | 50.0% |
| 2 | $1.22 | 104,183 | $127K | 50.0% |
| Total | $1.22 avg | 208,366 | $254K | 100% |
| Filing → |
| PAR | BUY | 2026-01-07 | $7.1M | — | Filing → |